732 related articles for article (PubMed ID: 20862250)
21. Evolution of induced pluripotent stem cell technology.
Zhou H; Ding S
Curr Opin Hematol; 2010 Jul; 17(4):276-80. PubMed ID: 20442654
[TBL] [Abstract][Full Text] [Related]
22. Screening of Human cDNA Library Reveals Two differentiation-Related Genes, HHEX and HLX, as Promoters of Early Phase Reprogramming toward Pluripotency.
Yamakawa T; Sato Y; Matsumura Y; Kobayashi Y; Kawamura Y; Goshima N; Yamanaka S; Okita K
Stem Cells; 2016 Nov; 34(11):2661-2669. PubMed ID: 27335261
[TBL] [Abstract][Full Text] [Related]
23. Mouse SCNT ESCs have lower somatic mutation load than syngeneic iPSCs.
Li Z; Lu H; Yang W; Yong J; Zhang ZN; Zhang K; Deng H; Xu Y
Stem Cell Reports; 2014 Apr; 2(4):399-405. PubMed ID: 24749065
[TBL] [Abstract][Full Text] [Related]
24. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
Liu Y; Deng W
Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
[TBL] [Abstract][Full Text] [Related]
25. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
Qi SD; Smith PD; Choong PF
ANZ J Surg; 2014 Jun; 84(6):E1-11. PubMed ID: 23035845
[TBL] [Abstract][Full Text] [Related]
26. DNA methylation dynamics in human induced pluripotent stem cells over time.
Nishino K; Toyoda M; Yamazaki-Inoue M; Fukawatase Y; Chikazawa E; Sakaguchi H; Akutsu H; Umezawa A
PLoS Genet; 2011 May; 7(5):e1002085. PubMed ID: 21637780
[TBL] [Abstract][Full Text] [Related]
27. Does transcription factor induced pluripotency accurately mimic embryo derived pluripotency?
Lowry WE
Curr Opin Genet Dev; 2012 Oct; 22(5):429-34. PubMed ID: 23079387
[TBL] [Abstract][Full Text] [Related]
28. Ectopic expression of CITED2 prior to reprogramming, promotes and homogenises the conversion of somatic cells into induced pluripotent stem cells.
Charneca J; Matias AC; Escapa AL; Fernandes C; Alves A; Santos JMA; Nascimento R; Bragança J
Exp Cell Res; 2017 Sep; 358(2):290-300. PubMed ID: 28684114
[TBL] [Abstract][Full Text] [Related]
29. Dynamic transcriptional and epigenomic reprogramming from pediatric nasal epithelial cells to induced pluripotent stem cells.
Ji H; Zhang X; Oh S; Mayhew CN; Ulm A; Somineni HK; Ericksen M; Wells JM; Khurana Hershey GK
J Allergy Clin Immunol; 2015 Jan; 135(1):236-44. PubMed ID: 25441642
[TBL] [Abstract][Full Text] [Related]
30. The metabolome of induced pluripotent stem cells reveals metabolic changes occurring in somatic cell reprogramming.
Panopoulos AD; Yanes O; Ruiz S; Kida YS; Diep D; Tautenhahn R; Herrerías A; Batchelder EM; Plongthongkum N; Lutz M; Berggren WT; Zhang K; Evans RM; Siuzdak G; Izpisua Belmonte JC
Cell Res; 2012 Jan; 22(1):168-77. PubMed ID: 22064701
[TBL] [Abstract][Full Text] [Related]
31. Defining differentially methylated regions specific for the acquisition of pluripotency and maintenance in human pluripotent stem cells via microarray.
He W; Kang X; Du H; Song B; Lu Z; Huang Y; Wang D; Sun X; Yu Y; Fan Y
PLoS One; 2014; 9(9):e108350. PubMed ID: 25250679
[TBL] [Abstract][Full Text] [Related]
32. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
Qi SD; Smith PD; Choong PF
ANZ J Surg; 2014 Jun; 84(6):417-23. PubMed ID: 24894037
[TBL] [Abstract][Full Text] [Related]
33. Comparative transcriptomic analysis identifies reprogramming and differentiation genes differentially expressed in UiPSCs and ESCs.
Shi L; Cui Y; Zhou X; Luan J; Wang L; Han J
Biosci Trends; 2017 Jul; 11(3):355-359. PubMed ID: 28529265
[TBL] [Abstract][Full Text] [Related]
34. Modulation of chromatin modifying factors' gene expression in embryonic and induced pluripotent stem cells.
Luzzani C; Solari C; Losino N; Ariel W; Romorini L; Bluguermann C; Sevlever G; Barañao L; Miriuka S; Guberman A
Biochem Biophys Res Commun; 2011 Jul; 410(4):816-22. PubMed ID: 21703227
[TBL] [Abstract][Full Text] [Related]
35. Mitochondrial Akt Signaling Modulated Reprogramming of Somatic Cells.
Chen YH; Su CC; Deng W; Lock LF; Donovan PJ; Kayala MA; Baldi P; Lee HC; Chen Y; Wang PH
Sci Rep; 2019 Jul; 9(1):9919. PubMed ID: 31289326
[TBL] [Abstract][Full Text] [Related]
36. Linking Telomere Regulation to Stem Cell Pluripotency.
Liu L
Trends Genet; 2017 Jan; 33(1):16-33. PubMed ID: 27889084
[TBL] [Abstract][Full Text] [Related]
37. Progress made in the reprogramming field: new factors, new strategies and a new outlook.
Hussein SM; Nagy AA
Curr Opin Genet Dev; 2012 Oct; 22(5):435-43. PubMed ID: 22959308
[TBL] [Abstract][Full Text] [Related]
38. Efficient hematopoietic redifferentiation of induced pluripotent stem cells derived from primitive murine bone marrow cells.
Pfaff N; Lachmann N; Kohlscheen S; Sgodda M; Araúzo-Bravo MJ; Greber B; Kues W; Glage S; Baum C; Niemann H; Schambach A; Cantz T; Moritz T
Stem Cells Dev; 2012 Mar; 21(5):689-701. PubMed ID: 21732815
[TBL] [Abstract][Full Text] [Related]
39. Pluripotent stem cell derivation and differentiation toward cardiac muscle: novel techniques and advances in patent literature.
Quattrocelli M; Thorrez L; Sampaolesi M
Recent Pat Drug Deliv Formul; 2013 Apr; 7(1):18-28. PubMed ID: 22974171
[TBL] [Abstract][Full Text] [Related]
40. Overlapping genes may control reprogramming of mouse somatic cells into induced pluripotent stem cells (iPSCs) and breast cancer stem cells.
Mosca E; Cocola C; Sabour D; Pelucchi P; Bertalot G; Palumbo O; Carella M; Götte M; Schöler HR; Reinbold R; Zucchi I; Milanesi L
In Silico Biol; 2010; 10(5-6):207-21. PubMed ID: 22430355
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
